Plantas medicinais com potencial para tratamento de transtornos de ansiedade e depressão: uma revisão integrativa

Author:

Garlet Tanea Maria BisogninORCID,Ruppelt Bettina MonikaORCID

Abstract

Sociobiodiversity can contribute to innovation in medicines from Brazilian plant diversity. This work sought to gather evidence from clinical studies on the effectiveness of using medicinal plants and herbal medicines in treating anxiety disorders and depression. Thus, an integrative review was carried out with a selection of plants from the work of Pio Corrêa (1926 - 1978) and through the PubMed, Lilacs and Cochrane databases. After applying the selection criteria, 43 articles were listed, and 12 plants were investigated. It was possible to demonstrate anxiolytic effects for saffron (Crocus sativus), cimicífuga (Actaea racemosa), dill (Anethum graveolens), orange (Citrus x aurantium), hops (Humulus lupulus), melissa (Melissa officinalis), passion fruit (Passiflora incarnata) and valeriana (Valeriana officinalis); antidepressants for saffron, curcuma (Curcuma longa), hops and melissa; sedatives for saffron, lettuce (Lactuca sativa), citron (Aloysia citriodora), hops, melissa, passion fruit and valeriana (Valeriana officinalis). Therefore, phytotherapy can help treat anxiety disorders and depression in mental health care, using plants from Brazilian sociobiodiversity. However, further investigations with clinical trials and investments in biotechnology are necessary to ensure the development of innovation in medicines of plant origin.

Publisher

Fiocruz - Instituto de Tecnologia em Farmacos

Reference83 articles.

1. Organização das Nações Unidas (ONU). 1 bilhão de pessoas vivem com algum transtorno mental, afirma OMS | ONU News, 2022; [acesso 25 mar. 2023]. Disponível em: [https://news.un.org/pt/story/2022/06/1792702].

2. Organização Pan-Americana da Saúde (OPAS). Pandemia de COVID-19 desencadeia aumento de 25% na prevalência de ansiedade e depressão em todo o mundo. OPAS. 2022; [acesso 7 abr. 2023]. Disponível em: [https://www.paho.org/pt/noticias/2-3-2022-pandemia-covid-19-desencadeia-aumento-25-na-prevalencia-ansiedade-e-depressao-em].

3. Neto MRL, Elkis H. Psiquiatria Básica. 2ª ed. Porto Alegre: ARTMED/ Grupo A; 2007. 712p. ISBN 9788536309606

4. Gotlib IH, Joormann J. Cognition and depression: current status and future directions. Annu Rev Clin Psychol. 2010; 6(1): 285–312. Disponível em: [https://doi.org/10.1146/annurev.clinpsy.121208.131305].

5. Brasil. Na América Latina, Brasil é o país com maior prevalência de depressão. 2022; [acesso em: 7 abr. 2023]. Disponível em: [https://www.gov.br/saude/pt-br/assuntos/noticias/2022/setembro/na-america-latina-brasil-e-o-pais-com-maior-prevalencia-de-depressao].

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3